Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were up 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The business has a fifty day simple moving average of C$0.08 and a two-hundred day simple moving average of C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Insider Selling Explained: Can it Inform Your Investing Choices?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What Are Earnings Reports?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Which Wall Street Analysts are the Most Accurate?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
